Cargando…
Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression
Stromal Derived Factor-1α (SDF-1α) and its cognate receptor CXCR4 play a key role in mediating breast cancer cell invasion and metastasis. Therefore, drugs able to inhibit CXCR4 activation may add critical tools to reduce tumor progression, especially in the most aggressive form of the breast cancer...
Autores principales: | Rovito, Daniela, Gionfriddo, Giulia, Barone, Ines, Giordano, Cinzia, Grande, Fedora, De Amicis, Francesca, Lanzino, Marilena, Catalano, Stefania, Andò, Sebastiano, Bonofiglio, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323141/ https://www.ncbi.nlm.nih.gov/pubmed/27556298 http://dx.doi.org/10.18632/oncotarget.11371 |
Ejemplares similares
-
The Role of PPARγ Ligands in Breast Cancer: From Basic Research to Clinical Studies
por: Augimeri, Giuseppina, et al.
Publicado: (2020) -
Natural and Synthetic PPARγ Ligands in Tumor Microenvironment: A New Potential Strategy against Breast Cancer
por: Augimeri, Giuseppina, et al.
Publicado: (2020) -
Modulating Tumor-Associated Macrophage Polarization by Synthetic and Natural PPARγ Ligands as a Potential Target in Breast Cancer
por: Gionfriddo, Giulia, et al.
Publicado: (2020) -
Nutraceuticals in the Mediterranean Diet: Potential Avenues for Breast Cancer Treatment
por: Augimeri, Giuseppina, et al.
Publicado: (2021) -
LPL, FNDC5 and PPARγ gene polymorphisms related to body composition parameters and lipid metabolic profile in adolescents from Southern Italy
por: Perrone, Benedetta, et al.
Publicado: (2022)